Treatment outcomes in the inpatient management of severe functional neurological disorder: a retrospective cohort study

IF 2.1 Q3 CLINICAL NEUROLOGY BMJ Neurology Open Pub Date : 2024-07-01 DOI:10.1136/bmjno-2024-000675
Chloe Saunders, Hetashi Bawa, Daron Aslanyan, Frances Coleman, Helen Jinadu, Natasha Sigala, Nick Medford
{"title":"Treatment outcomes in the inpatient management of severe functional neurological disorder: a retrospective cohort study","authors":"Chloe Saunders, Hetashi Bawa, Daron Aslanyan, Frances Coleman, Helen Jinadu, Natasha Sigala, Nick Medford","doi":"10.1136/bmjno-2024-000675","DOIUrl":null,"url":null,"abstract":"Background Functional neurological disorder (FND) is a heterogeneous condition; severe forms can be disabling. Multidisciplinary treatment and rehabilitation are recommended for severe FND, but there remains a lack of evidence for its efficacy and lack of understanding of the predictors and components of recovery. Methods We report clinical outcome data for an inpatient cohort with severe FND. Clinical Global Impression Improvement with treatment is the primary outcome measure. Admission and discharge measures (Euroqol quality of life measures, Beck Depression Inventory, Spielberger Trait Anxiety Inventory, Cambridge Depersonalisation Scale, Illness Perception Questionnaire (Revised) and Functional Mobility Scale) are reported as secondary outcomes. Results We describe an FND cohort (n=52) with chronic illness (mean symptom duration 9.7 years). At admission, there were clinically relevant levels of depression, anxiety and depersonalisation derealisation. At the time of discharge, most (43/52) patients’ global condition had improved. Measures of mobility, depression and quality of life also significantly improved while at discharge, symptoms were experienced as more understandable and less distressing than at admission. An admission measure of patient confidence in treatment was predictive of eventual clinical outcome. Conclusions The most frequent outcome of inpatient rehabilitation is global improvement, even when symptoms are chronic and severe, reflected in measurable changes in both physical and psychological functioning. Significant levels of depersonalisation derealisation seen in this patient group suggest that routine enquiry into such experiences could help personalise FND treatment approaches. Patient confidence in treatment is key in determining clinical outcomes. As stated in the paper, data generated using the CRIS system need to remain within the SLAM firewall, but it is possible for these data to be released on reasonable request and the obtaining of the necessary permissions.","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"14 1","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Neurology Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjno-2024-000675","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background Functional neurological disorder (FND) is a heterogeneous condition; severe forms can be disabling. Multidisciplinary treatment and rehabilitation are recommended for severe FND, but there remains a lack of evidence for its efficacy and lack of understanding of the predictors and components of recovery. Methods We report clinical outcome data for an inpatient cohort with severe FND. Clinical Global Impression Improvement with treatment is the primary outcome measure. Admission and discharge measures (Euroqol quality of life measures, Beck Depression Inventory, Spielberger Trait Anxiety Inventory, Cambridge Depersonalisation Scale, Illness Perception Questionnaire (Revised) and Functional Mobility Scale) are reported as secondary outcomes. Results We describe an FND cohort (n=52) with chronic illness (mean symptom duration 9.7 years). At admission, there were clinically relevant levels of depression, anxiety and depersonalisation derealisation. At the time of discharge, most (43/52) patients’ global condition had improved. Measures of mobility, depression and quality of life also significantly improved while at discharge, symptoms were experienced as more understandable and less distressing than at admission. An admission measure of patient confidence in treatment was predictive of eventual clinical outcome. Conclusions The most frequent outcome of inpatient rehabilitation is global improvement, even when symptoms are chronic and severe, reflected in measurable changes in both physical and psychological functioning. Significant levels of depersonalisation derealisation seen in this patient group suggest that routine enquiry into such experiences could help personalise FND treatment approaches. Patient confidence in treatment is key in determining clinical outcomes. As stated in the paper, data generated using the CRIS system need to remain within the SLAM firewall, but it is possible for these data to be released on reasonable request and the obtaining of the necessary permissions.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
严重功能性神经紊乱住院治疗的疗效:一项回顾性队列研究
背景功能性神经失调症(FND)是一种异质性疾病,严重者可致残。对于重度 FND,建议进行多学科治疗和康复,但目前仍缺乏疗效证据,也不了解康复的预测因素和组成部分。方法 我们报告了一组重度 FND 住院患者的临床结果数据。临床总体印象改善是衡量治疗效果的主要指标。入院和出院测量(Euroqol 生活质量测量、贝克抑郁量表、斯皮尔伯格特质焦虑量表、剑桥人格解体量表、疾病感知问卷(修订版)和功能移动量表)作为次要结果进行报告。结果 我们描述了一个患有慢性疾病(平均症状持续时间为 9.7 年)的 FND 队列(n=52)。入院时,患者存在临床相关程度的抑郁、焦虑和人格解体。出院时,大多数患者(43/52)的整体状况有所改善。患者的活动能力、抑郁程度和生活质量也明显改善,出院时的症状比入院时更容易理解,痛苦程度也有所减轻。入院时对患者治疗信心的测量可预测最终的临床结果。结论 住院康复治疗最常见的结果是全面改善,即使症状是慢性的、严重的,也能通过身体和心理功能方面可测量的变化反映出来。在这一患者群体中,人格解体和去理想化的程度很高,这表明对这些经历进行常规调查有助于个性化 FND 治疗方法。患者对治疗的信心是决定临床结果的关键。正如论文中所述,使用 CRIS 系统生成的数据需要保留在 SLAM 防火墙内,但如果提出合理要求并获得必要许可,这些数据是可以公开的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMJ Neurology Open
BMJ Neurology Open Medicine-Neurology (clinical)
CiteScore
3.20
自引率
3.70%
发文量
46
审稿时长
13 weeks
期刊最新文献
Undiagnosed major risk factors in acute ischaemic stroke patients in Qatar: analysis from the Qatar stroke registry. Late-onset myopathy responsive to immunomodulatory treatment: sporadic late-onset nemaline myopathy without nemaline rods? Catatonia in anti-NMDA receptor encephalitis: a case series and approach to improve outcomes with electroconvulsive therapy. Analysis of door-to-needle time for thrombolysis in acute ischaemic stroke using statistical process control charts. Statins are rarely prescribed for incidentally discovered covert cerebrovascular disease: a retrospective cohort in a large electronic health record (EHR) identified using natural language processing.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1